Anebulo Pharmaceuticals I... (ANEB)

AI Score

Unlock

1.02

0.00 (0.00%)

At close: Apr 07, 2025, 3:59 PM

1.10

7.57%

After-hours: Apr 07, 2025, 04:02 PM EDT

Anebulo Pharmaceuticals Income Statement

Chart Mode

Financials in USD. Fiscal year is July - June.

Chart Mode

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Cash & Equivalents	15M	1.4M	3.09M	5.15M	6.64M	8.52M	11.25M	14.16M	16.36M	19.21M	14.55M	16.55M	18.01M	19.21M	19.99M	3.31M	2.48M	-3.02M	3.02M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.05M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	445.73K	505.43K	565.12K	624.82K	684.51K	n/a	422.75K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.67M	392.73K	101.65K	-3.02M	n/a
Receivables	30.76K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	23.07K	n/a	n/a	3.5K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	397.02K	245.36K	n/a	223.68K	171.74K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	568.59K	n/a	n/a	n/a
Total Current Assets	15.4M	1.96M	3.51M	5.37M	6.82M	9.05M	11.67M	14.43M	16.89M	19.82M	14.55M	17.25M	18.96M	20.5M	19.99M	3.9M	2.51M	3.02M	3.03M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	445.73K	505.43K	565.12K	624.82K	684.51K	n/a	422.75K	n/a	n/a	n/a	1.03M	n/a	n/a	n/a	1.67M	392.73K	101.65K	-3.02M	n/a
Total Assets	15.84M	2.47M	4.07M	6M	7.5M	9.05M	11.67M	14.43M	16.89M	19.82M	15.58M	17.25M	18.96M	20.5M	21.65M	4.29M	2.61M	n/a	3.03M
Account Payables	319.51K	252.14K	156.43K	384.92K	318.68K	565.95K	534.54K	570.9K	346.55K	523.47K	380.83K	83.28K	42.94K	493.82K	110.05K	82.03K	84.48K	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	209.35K	n/a	201.29K
Other Current Liabilities	n/a	n/a	n/a	n/a	-694.88K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	22.58K
Total Current Liabilities	878.8K	569.23K	260.58K	1.01M	1.01M	716.56K	1.07M	1.49M	1.37M	698.18K	512.53K	85.78K	49.94K	607.71K	241.63K	293.17K	353.77K	n/a	223.87K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	559.28K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	13.43M	2.98M	n/a	n/a
Total Long-Term Liabilities	559.28K	n/a	n/a	625.4K	694.88K	150.61K	534.26K	n/a	1.03M	n/a	380.83K	83.28K	42.94K	493.82K	110.05K	13.43M	2.98M	n/a	n/a
Total Liabilities	878.8K	569.23K	260.58K	1.01M	1.01M	716.56K	1.07M	1.49M	1.37M	698.18K	512.53K	85.78K	49.94K	607.71K	241.63K	13.73M	3.33M	n/a	223.87K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	209.35K	n/a	201.29K
Common Stock	41.09K	25.93K	25.93K	25.93K	25.93K	25.63K	25.63K	25.63K	25.63K	25.63K	23.34K	23.34K	23.34K	23.34K	23.34K	12.98K	12.98K	n/a	12K
Retained Earnings	-70.07M	-67.6M	-65.4M	-64.05M	-62.4M	-59.68M	-57.2M	-54.71M	-51.91M	-48.08M	-45.47M	-43.15M	-41.27M	-40.2M	-38.64M	-9.53M	-768.12K	n/a	-183.14K
Comprehensive Income	n/a	n/a	n/a	n/a	0.00	0.00	0.00	-0.00	-0.00	n/a	n/a	-0.00	0.00	n/a	-0.00	-2.98B	-0.00	-171.14K	n/a
Shareholders Equity	14.96M	1.9M	3.81M	4.99M	6.49M	8.33M	10.6M	12.94M	15.52M	19.12M	15.07M	17.16M	18.91M	19.89M	21.41M	-9.44M	-719.02K	2.8M	2.8M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.05M	n/a